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Nitric oxide is a gaseous messenger involved in the
regulation of several physiologic processes in various
cell types, including skin cells. Three different nitric
oxide synthases (neuronal nitric oxide synthase,
endothelial nitric oxide synthase, inducible nitric
oxide synthase) have been identi®ed in human cells.
For inducible nitric oxide synthase, an inducibility by
cytokines and lipopolysaccharides have been found.
For murine melanoma cells, a connection between
elevated levels of nitric oxide after inducible nitric
oxide synthase induction and consequent apoptosis
had been described. By northern analysis, we detected
inducible nitric oxide synthase mRNA in four of 15
human melanoma cell lines cultured without indu-
cible nitric oxide synthase inducing cytokines.
Induction of inducible nitric oxide synthase mRNA
by tumor necrosis factor-a, interferon-g, and lipopo-
lysaccharides was seen in normal human melanocytes
but not in melanoma cell lines. In accordance, indu-
cible nitric oxide synthase protein expression was
clearly inducible in cultures of normal melanocytes,
whereas in six melanoma cell lines investigated, indu-
cible nitric oxide synthase was found weakly
expressed already before treatment with tumor necro-
sis factor-a, interferon-g, and lipopolysaccharides,
and its expression was not inducible. The apoptotic
rates both in normal melanocytes and in two mela-
noma cell lines (SK-Mel-19 and O-Mel-2) were
increased by treatment with tumor necrosis factor-a,
interferon-g, and lipopolysaccharides; however, these
effects could not be prevented by the speci®c nitric
oxide synthase inhibitor NG-monomethyl-L-arginine.
These data reveal a clear-cut difference between
human melanoma cell lines and cultured normal
human melanocytes with respect to inducible nitric
oxide synthase inducibility. Although the data do not
support the hypothesis that inducible nitric oxide
synthase is an important regulator for apoptosis in
human melanoma cells, the regulation de®ciency
found for melanoma cells may be of importance for
melanocytic transformation and tumor progression.
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R
esistance against pro-apoptotic stimuli may be a key
factor for melanoma progression. Several signaling
cascades and proteins leading to and involved in
apoptosis have been described (Nagata, 1997). Also,
expression of the inducible nitric oxide synthase
(iNOS) and concomitant formation of high levels of NO had been
suggested to cause apoptosis in murine K1735 melanoma cells (Xie
et al, 1997).
NO is a gaseous intracellular and extracellular messenger released
in mammalian cells as a product of the reaction from arginine to
citrullin. Of three different NOS reported, the neuronal NOS
(nNOS, NOS I) and the endothelial NOS (eNOS, NOS III) are
predominantly expressed in neuronal and endothelial cells, respect-
ively, and their activity is regulated by Ca2+ and calmodulin.
Recent studies demonstrated that the expression of eNOS and
nNOS may also be in¯uenced by the growth status, stress signals, or
cytokines and lipopolysaccharide (LPS; FoÈrstermann et al, 1998).
The predominant function of nNOS is signal transduction between
neighboring neurons, whereas eNOS contributes to the modula-
tion of the vascular tone (FoÈrstermann et al, 1998). The iNOS
(NOS II), was found to be expressed in response to cytokines and
LPS. Its activity is not regulated by intracellular Ca2+, and it was
detected in a variety of different cell types, including keratinocytes
(Stallmeyer et al, 1999), ®broblasts (Wang et al, 1997), and
Langerhans cells (Qureshi et al, 1996). In macrophages, iNOS
activity and production of elevated levels of NO were shown to be
directly involved in the defense against pathogens. On the other
hand, high levels of iNOS in in®ltrating macrophages and epithelial
cells may contribute to autoimmune and chronically in¯ammatory
diseases (KroÈncke et al, 1998). All NOS require several cofactors,
among which tetrahydrobiopterin has been reported to be
absolutely necessary for the formation of enzymatically active
iNOS dimers (Gross and Levi, 1992; Tzeng et al, 1995).
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A positive relation between apoptosis and iNOS expression has
been described for several cell types, including K1735 murine
melanoma cells (Xie et al, 1997), MCF-7 mammary carcinoma cells
(Binder et al, 1999), murine macrophages, and rat pancreatic b-cells
(Dimmeler and Zeiher, 1997). Induction of iNOS in K1735
murine melanoma cells was achieved by treatment with interferon
(IFN)-g in combination with either interleukin-1b, tumor necrosis
factor (TNF)-a, or LPS. In subclones of K1735, an inverse
correlation was further shown between iNOS expression and
metastatic potential in nude mice (Dong et al, 1994).
Concerning the expression of iNOS in human melanocytic cells,
several studies have been reported that are based on immuno-
histochemistry. Higher levels of iNOS were found in subcutaneous
and lymph node metastases of nonprogressive melanoma as
compared with metastases of progressive melanoma (Tschugguel
et al, 1999), whereas iNOS was found to be expressed to a lower
extent in metastases as compared with nevi and primary melanomas
(Ahmed and Van den Oord, 2000). Also expression of iNOS in
lymph node and in-transit metastases was discussed as an indicator
for poor prognosis (Ekmekcioglu et al, 2000). Recently, even
constitutive expression of iNOS was reported for normal
melanocytes from adult donors and for melanoma cell lines
established from metastatic lesions (Salvucci et al, 2001), whereas
Rocha and Guillo (2001) reported inducibility of iNOS in cultured
human melanocytes in response to treatment with cytokines and
LPS.
Based on these data, the role of iNOS for melanoma progression
and its possible relationship with apoptosis was discussed contro-
versially. There were to our knowledge no clear molecular data
con®rming expression and inducibility of iNOS protein and RNA
in normal human melanocytes (NHM) and melanoma cells in
addition to data obtained by immunohistochemistry. We therefore
studied iNOS expression in human melanoma cell lines and
cultures of NHM on the RNA and protein level and investigated
its relation to apoptosis by using TNF-a, IFN-g, and LPS for iNOS
induction as well as NG-monomethy-L-arginine (L-NMMA) for
iNOS inhibition.
MATERIALS AND METHODS
Cell lines and culture conditions Human melanoma cell lines and the
mammary carcinoma cell line MCF-7 (Binder et al, 1999) used as a
positive control, were grown routinely in melanoma medium consisting
of Dulbecco's minimal Eagle's medium with 4.5 g glucose per liter and
phenol red (Gibco, Paisley, U.K.) supplemented with 10% fetal bovine
serum and antibiotics. For induction of iNOS the same medium lacking
phenol red and buffered with 25 mM HEPES was used.
Cultures of NHM were established from foreskins by trypsin digestion
and by cultivation in melanocyte medium (Eberle et al, 1999), which
consisted of MCDB 153 (Biochrom, Berlin, Germany) supplemented
with 2 mM Ca2+, 5 mg insulin per ml (Sigma, Deisenhofen, Germany),
10 mg human transferrin per ml (Sigma), 0.4% vol/vol whole bovine
pituitary extract (Gibco), 2 ng per ml bovine basic ®broblast growth
factor (Boehringer, Mannheim, Germany), 1 nM cholera toxin
(Calbiochem, Bad Soden, Germany) and 50 mM hydrocortisone (Serva,
Heidelberg, Germany).
Of the 15 human melanoma cell lines used, six originated from
primary tumors (A375, Bro, IGR-39, JPC-298, Mel-HO, and Mel-
Juso), and nine originated from metastases (O-Mel-2, SK-Mel-19, SK-
Mel-13, SK-Mel-23, SK-Mel-28, MeWo, Mel-2a, IGR-37, and M-5)
(for a list of references to the cell lines used, see Eberle et al, 1999).
Induction of iNOS Human melanoma cell lines and MCF-7 cells
were treated in melanoma medium for 24±72 h as indicated with 100 U
human recombinant TNF-a per ml (Sigma), 100 U human recombinant
IFN-g per ml (Boehringer), and 0.2 mg LPS per ml (Sigma).
Concentration of cytokines and LPS and the incubation times were
chosen in close relation to the conditions used for murine melanoma
cells (Dong et al, 1994). To keep background apoptosis low, enzyme-
linked immunosorbent assays were performed after 24 h. In order to
generate comparable growth conditions for normal melanocytes and
melanoma cells, primary melanocytes that were routinely grown in
melanocyte medium, were washed once with melanoma medium and
treated with TNF-a, IFN-g, and LPS as described above. As shown
earlier, NHM can be maintained in melanoma medium for up to 2 wk
(Eberle et al, 1993).
Detection of iNOS by western blot analysis Proteins were isolated
from the respective cells grown for 72 h in the presence or absence of
iNOS-inducing agents at a con¯uence of 60±80%. Cells were trypsinized
and resuspended in cell lysis buffer [20 mM Tris±HCl, pH 7.5, 137 mM
NaCl, 1 mM phenylmethylsulfonyl ¯uoride, 10 mg aprotinin per ml,
10 mg leupeptin per ml, 5 mg pepstatin per ml, 0.5% sodium dodecyl
sulfate (SDS)]. For homogenization, cell suspensions were passed for
several times through a 26-gauge needle. After 5 min centrifugation at
12,000 3 g, the protein content of the supernatants was determined
using the BCA Protein Assay Reagent (Pierce, St Augustin, Germany).
A 50 mg aliquot of the supernatants was denatured with loading buffer
and separated by electrophoresis under reducing conditions on 8% SDS±
polyacrylamide gels in parallel with a broad range prestained SDS±
polyacrylamide gel electrophoresis protein standard (Bio-Rad, Munich,
Germany). Proteins were transferred to Protran BA85 nitrocellulose
membranes (Schleicher & SchuÈll, Dassel, Germany) by electroblotting
(Bio-Rad). Equal loading of proteins was examined by staining the
membranes with Ponceau S solution (Sigma) or by staining SDS gels
run in parallel by a colloidal Coomassie staining (Roth, Karlsruhe,
Germany). The blot was blocked overnight and iNOS was detected on
Hyper®lm ECL (Amersham Pharmacia Biotech, Freiburg, Germany)
after successive incubations with a polyclonal iNOS anti-serum (iNOS
Ab1; Transduction Laboratories, PharminGen Europe, Heidelberg,
Germany), anti-rabbit IgG peroxidase conjugate (Transduction
Laboratories) and ECL-western blotting detection reagents (Amersham
Pharmacia Biotech). The chemiluminescence signals on Hyper®lm ECL
were semiquantitatively analyzed by the TINA program (Raytest,
Straubenhardt, Germany). Experiments for the detection of iNOS on
western blots were repeated three times with lysates generated
independently from melanoma cells grown in the presence or absence of
TNF-a, IFN-g, and LPS. Inducibility of iNOS protein in human
melanocytes was studied in six independently generated NHM cultures
from different donors. Expression of iNOS protein was also studied by
western analysis using a second immunoassay performed with the
polyclonal antibody N20 (iNOS Ab2; Santa Cruz, Heidelberg, Germany)
and a different anti-rabbit IgG peroxidase conjugate (Dako, Hamburg,
Germany).
RNA extraction and northern blot analysis RNA was isolated from
melanoma cells grown without iNOS-inducing agents during the
logarithmic growth phase, 24 h after applying fresh growth medium. For
analysis of iNOS mRNA inducibility, normal melanocytes, SK-Mel-19
and MCF-7 cells were incubated with or without cytokines and LPS for
24 h and 48 h, respectively. Total RNA was isolated from trypsinized
cells using the RNeasy Mini Kit (Qiagen, Hilden, Germany). Total
RNA (30 mg) was separated on 1.2% formaldehyde/agarose gels, RNA
was transferred on to Gene Screen Plus membranes (NEN Life Science,
Cologne, Germany) and hybridized at 60°C. For detection of iNOS, a
cDNA probe containing nucleotides 1057±3119 of human hepatocyte
iNOS cDNA, which was a gift of T.R. Billiar (Department of Surgery,
University of Pittsburgh, Pittsburgh, PA) was used (Geller et al, 1993).
The membrane was washed under stringent conditions (45 min at 65°C
in 2 3 sodium citrate/chloride buffer) and exposed to an imaging plate
for quanti®cation of radioactivity by a BAS-1500 Phosphoimager (Fuji
Photo, Nakanuma, Japan).
Quanti®cation of apoptosis Melanoma cells and NHM were seeded
on to six-well plates (2 3 105 cells per well) with 2 ml of the respective
medium. At a con¯uence of 50±80%, the cultures were washed once
with melanoma medium and were then incubated in 2 ml of melanoma
medium for 24 h in the presence or absence of cytokines and LPS. In
addition, the iNOS cofactor tetrahydrobiopterin (Sigma) was used at
50 mM; and two different lots of the NO-synthase inhibitor L-NMMA
purchased from Sigma and Alexis (GruÈnberg, Germany), respectively,
were used at a concentration of 1.5 mM. After incubation, cell culture
plates were centrifuged for 10 min at 200 3 g and apoptosis was
quanti®ed by detection of mononucleosomes and oligonucleosomes
using the Cell Death Detection enzyme-linked immunosorbent assay
(Roche Diagnostics, GmbH, Mannheim, Germany) following the
protocol for adherent cells as recommended by the manufacturer.
Enzyme-linked immunosorbent assay values were normalized by the
con¯uency of the cultures. Relative apoptotic rates of cells treated with
different agents were calculated as the ratio of the normalized values of
treated and control cells. The apoptotic rates of untreated cells were set
to 1. Each assay consisted of duplicate values, and at least three
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independent experiments were performed. Mean values were calculated
from the relative apoptotic rates of triplicate experiments. In parallel to
apoptosis, relative cytotoxicity levels were determined by measuring
lactic dehydrogenase activity in the culture ¯uids using the cytotoxicity
detection kit (Roche) as described by Wieder et al (1998). Loss of
adherence of cells as a further indication of apoptotic cell death was
monitored microscopically and quanti®ed by counting the number of
adherent cells 3 d after induction.
Analysis of nitrite and nitrotyrosine Nitrite in the culture ¯uid was
quanti®ed by two different assays: (i) Griess reagent (Granger et al, 1996),
and (ii) measurement of ¯uorescence of 1(H)-naphtotriazole formed after
reaction of nitrite with 2,3-diaminonaphtalene. For the Griess assay,
cellular debris was removed by centrifugation for 5 min at 10,000 3 g.
Equal volumes of the supernatant and of the Griess reagent (1%
sulfanilamide, 0.1% naphtylethylene diaminedihydrochloride, 2.5%
phosphoric acid) were mixed. After 10 min at room temperature the
absorbance at 540 nm was determined. Nitrite measurements using 2,3-
diaminonaphtalene were performed with the nitrate/nitrite ¯uorometric
assay kit (Alexis, GruÈnberg, Germany) essentially as recommended by the
manufacturer. For this assay the culture ¯uid of NHM was centrifuged
through microcon YM10 centrifugal ®lter devices (Millipore, MA) with
an exclusion limit of 10 kDa. For both assays, standard curves using
different concentrations of sodium nitrite dissolved in growth medium
were established.
As another stable NO product, proteins with nitrotyrosine residues
were analyzed by western blotting (Ter Steege et al, 1998). Western blots
were incubated with a monoclonal antibody (clone HM1) to nitro-
tyrosine (Trinova Biochem GmbH, Giessen, Germany), followed by
incubation with peroxidase labeled anti-mouse IgG (Dako).
RESULTS
Detection of iNOS mRNA in melanoma cell lines Expres-
sion of iNOS mRNA was studied by northern hybridization of
total RNA from 15 melanoma cell lines grown without iNOS
inducing cytokines and LPS. Unexpectedly, iNOS mRNA with a
size of approximately 4200 M was clearly detectable as faint signals
in the melanoma cell lines O-Mel-2, SK-Mel-19, SK-Mel-13, and
SK-Mel-23 (Fig 1A). These four cell lines originated from
melanoma metastases, whereas in all melanoma cell lines
originating from primary tumors (A375, Bro, IGR-39, JPC-298,
Mel-HO, and Mel-Juso) and in some other cell lines from
metastases (SK-Mel-28, Mewo, Mel-2a, IGR-37, and M-5) no
iNOS mRNA was detected.
In order to investigate the inducibility of iNOS, total RNA of
three cultures of NHM and of two melanoma cell lines (SK-Mel-
19 and O-Mel-2) all grown either with or without TNF-a, IFN-g,
and LPS, were analyzed by northern hybridization. MCF-7
mammary carcinoma cells, for which expression of iNOS in
response to inducing agents had already been reported (Binder
et al, 1999), were used as the positive control. Without induction,
weak expression of iNOS mRNA was seen. Inducibility of
iNOS mRNA was detected only in MCF-7 and in one of three
normal melanocyte cultures analyzed, whereas in SK-Mel-19 and
O-Mel-2, iNOS mRNA was not inducible (Fig 1B).
Expression of iNOS protein in melanoma cell lines and
human melanocyte cultures To expand our original data on
iNOS expression restricted to the RNA level, we investigated
expression of iNOS protein in melanocytic cells. Lysates of six
melanoma cell lines (Mel-2a, MeWo, O-Mel-2, SK-Mel-19, SK-
Mel-23, and SK-Mel-28) and of six NHM cultures as well as of the
control cell line MCF-7 were analyzed by western blotting using a
polyclonal iNOS antibody preparation (iNOS Ab1). In MCF-7
cells, a 150 kDa iNOS protein was detected that was induced in
response to TNF-a, IFN-g, and LPS treatment (Fig 2A). An
unspeci®c protein band with a molecular mass of 140 kDa was due
to the secondary antibody, the anti-rabbit IgG peroxidase conjugate
used in the immune reaction. This was proven by incubation with
the secondary antibody alone (Fig 2B). The unspeci®c protein was
detected on all western blots performed with this conjugate (see
Fig 3). It was abundant in MCF-7 and melanoma cells but was not
expressed in NHM (Fig 2).
In untreated cultures of NHM and melanoma cell lines, only
weak iNOS protein bands were detected. Of the melanoma cell
lines analyzed, the strongest iNOS signals were seen in SK-Mel-19
Figure 1. Detection of iNOS mRNA in melanocytic cells. (A)
Total RNA isolated from a panel of different melanoma cell lines grown
in the absence of TNF-a, IFN-g, and LPS was analyzed by northern
hybridization. Only in melanoma cell lines O-Mel-2, SK-Mel-13, SK-
Mel-19, and SK-Mel-23 weak signals for iNOS mRNA with a size of
4200 nucleotides were detected. (B) Total RNA isolated from two
melanocyte cultures (NHM-A5 and NHM-A6), the mammary
carcinoma cell line MCF-7 used as a control, and the melanoma cell
lines SK-Mel-19 and O-Mel-2 was analyzed by northern hybridization.
Cultures were grown for 24 h (NHM-A6) or 48 h (MCF-7, NHM-A5,
and SK-Mel-19) either in the presence (+) or absence (±) of TNF-a,
IFN-g, and LPS. (A, B) Thirty micrograms of RNA were loaded per
lane and iNOS mRNA was detected by a human hepatocyte iNOS
probe.
Figure 2. Identi®cation of iNOS protein in melanocytic cells
grown in the absence of iNOS inducing agents. The expression of
the iNOS protein in the absence of iNOS inducing agents was
investigated by western analysis in NHM-1 and cells from human
melanoma cell lines (Mel-2a, MeWo, O-Mel-2, SK-Mel-19, SK-Mel-
23, and SK-Mel-28). As a control, iNOS expression in the mammary
carcinoma cell line MCF-7 treated with (+) or without TNF-a, IFN-g,
and LPS is shown. The western blot A was incubated with the iNOS-
speci®c rabbit antibody (iNOS Ab1) followed by an incubation with the
anti-rabbit IgG peroxidase conjugate, whereas the duplicate blot B was
incubated only with the anti-rabbit IgG peroxidase conjugate. iNOS was
detected on blot A as a 150 kDa protein, which was not present on blot
B. Unexpectedly, the anti-rabbit peroxidase conjugate detected an
unspeci®c protein band (140 kDa) as seen on blot B, which was also
found on blot A beneath the iNOS signal. The experiment was repeated
three times; one representative western blot is shown.
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and O-Mel-2 cells (Figs 2, 3). Unexpectedly, iNOS protein was
not inducible in melanoma cell lines by treatment with TNF-a,
IFN-g, and LPS, whereas in NHM cultures, the amount of iNOS
protein was clearly elevated after treatment with iNOS inducing
agents (Fig 3). Owing to densitometric measurement of ®ve
independent melanocyte cultures, an average induction factor of
3.5 (SD = 1.5) was determined.
The results obtained with iNOS Ab1 were con®rmed using a
second iNOS speci®c antibody. In lysates of NHM, iNOS Ab2
detected the same 150 kDa protein as detected by iNOS Ab1
(Fig 4A). Furthermore, the expression patterns of the 150 kDa
iNOS protein detected by iNOS Ab2 and iNOS Ab1 were
identical (Figs 3 and 4B).
The RNA and protein data are summarized in Table I. In
MCF-7 mammary carcinoma cells both iNOS mRNA and protein
was inducible; in normal melanocytes, iNOS protein was inducible,
whereas the iNOS mRNA was induced in one of three cultures,
investigated. On the other hand, melanoma cell lines never showed
inducibility of either mRNA or protein, even mRNA expression
in most melanoma cell lines was at the detection limit.
Induction of apoptosis by TNF-a, IFN-g, and LPS Incub-
ation of SK-Mel-19 and O-Mel-2 melanoma cells and of NHM
with TNF-a, IFN-g, and LPS for 3 d resulted in a signi®cant
decrease of the number of cells adherent to the culture vessel
(Fig 5). This effect was accompanied with a high number of
detached rounded cells ¯oating in the growth medium of
melanoma cell cultures treated with cytokines and LPS,
indicating apoptosis. In order to investigate the role of iNOS in
possible apoptotic events, two melanoma cell lines, SK-Mel-19 and
O-Mel-2, characterized by the highest expression of iNOS protein,
as well as seven NHM cultures were grown with or without
TNF-a, IFN-g, and LPS. In addition, the effects of the NOS
inhibitor L-NMMA and the iNOS cofactor tetrahydrobiopterin on
apoptosis were investigated. Addition of this cofactor to cultures of
vascular smooth muscle cells and NIH3T3 ®broblasts both
expressing iNOS, resulted in an increase of NO production
(Gross and Levi, 1992; Tzeng et al, 1995) indicating that this
cofactor was limiting for iNOS activity and could be supplied by
the growth medium.
Apoptosis was quanti®ed in cells treated with different agents by
determination of the increase of mononucleosomes and oligo-
nucleosomes in comparison with untreated control cells. In all
experiments performed with SK-Mel-19 and O-Mel-2, elevated
apoptotic rates were found after treatment with TNF-a, IFN-g,
and LPS (mean values 3.6 and 3.2, respectively; Table II). In
contrast, only in three of seven NHM cultures analyzed, elevated
apoptosis was found in response to treatment with cytokines and
LPS. Cytotoxicity values as determined by the lactic dehydrogenase
assay were not found to be elevated regularly upon treatment with
cytokines and LPS, and no correlation between elevated apoptotic
rates and cytotoxicity was seen (data not shown).
Addition of the NOS inhibitor L-NMMA to melanoma cells and
NHM cultures did not show any inhibitory effect on apoptosis
induced by TNF-a, IFN-g, and LPS. In agreement, incubation
with the iNOS cofactor tetrahydrobiopterin did not cause a
signi®cant increase of apoptosis, as would be expected if this
cofactor is limiting for iNOS-dependent apoptosis (Table I).
Control incubation of the cells with either L-NMMA or
tetrahydrobiopterin alone did not result in any signi®cant change
of the basal apoptotic rates. Thus, these results indicate that
apoptosis in response to cytokines and LPS is not dependent on
iNOS neither in NHM nor in melanoma cells.
NO release is not enhanced by iNOS inducing agents in
melanocytic cells The release of NO was investigated by two
different assays for the stable product nitrite in culture ¯uid and in
addition, nitration of cellular proteins was studied. For melanoma
cell lines SK-Mel-19 and O-Mel-2 grown for 3 d in the presence
or absence of cytokines and LPS, the nitrite level measured by the
Griess reaction was below the detection limit of 1 mM. Only for
some of the normal melanocytes cultures studied, nitrite levels were
measurable; however, results determined with the Griess reaction
for melanocytes were dif®cult to interpret because in response to
cytokines and LPS, also an increase of melanin in the growth
medium was found, which interfered with the photometric
measurement. In the second nitrite assay, based on 2,3
Figure 4. Con®rmation of identity of the 150 kDa iNOS protein
by western analysis using a second iNOS-speci®c antibody (iNOS
Ab2). (A) iNOS Ab2 detects the same 150 kDa protein as detected by
iNOS Ab1. Expression and inducibility of iNOS protein were
investigated in cell lysates of a NHM culture (NHM-3) grown in the
presence (+) or absence (±) of TNF-a, IFN-g, and LPS using either
iNOS Ab1 or iNOS Ab2. (B) The iNOS protein detected by iNOS
Ab2 has the same expression pattern as the protein detected by iNOS
Ab1. A western blot of a NHM culture (NHM-7) and of SK-Mel-19
and O-Mel-2 melanoma cells grown in the presence (+) or absence (±)
of cytokines and LPS is shown. As a control, MCF-7 cells grown with
cytokines and LPS were also assayed. iNOS was detected by iNOS Ab2.
For the immunoreaction, the peroxidase labeled anti-rabbit IgG reagent,
was also substituted. This secondary antibody did not react with the
unspeci®c 140 kDa protein (see Figs 2 and 3).
Figure 3. iNOS is not inducible in melanoma cell lines. Expression
of iNOS and inducibility was investigated by western analysis in six
melanoma cell lines (O-Mel-2, SK-Mel-19, SK-Mel-23, SK-Mel-28,
Mel-2a, and MeWo) and ®ve cultures of NHM originating from
different donors (NHM-2, -3, -4, -5, -6) using iNOS Ab1. Cells were
incubated for 3 d in the presence (+) or absence (±) of TNF-a, IFN-g,
and LPS. As a control, lysates of MCF-7 cells treated in the same way
were analyzed in parallel. The speci®c iNOS signals are indicated. In one
of the NHM cultures analyzed (NHM-4) treatment with cytokines and
LPS resulted in the induction of a second signal of 140 kDa.
Experiments with the six melanoma cell lines were repeated at least three
times. One representative western blot is shown.
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diaminonaphtalene, the melanin could be removed from the
growth medium by ultra®ltration. Nitrite levels for melanoma cell
lines SK-Mel-19 and O-Mel-2 were still below the detection limit
of 0.4 mM, whereas for NHM, nitrite levels were determined
between 0.5 and 0.8 mM. Nitrite did not increase, however, in
response to cytokines and LPS, nor L-NMMA had any effect
(Table III). Similarly, nitrotyrosine incorporated in cellular
proteins was not elevated in induced cells (Fig 6).
DISCUSSION
iNOS, which is expressed in response to cytokine and/or LPS
stimulation, is independent of Ca2+ activation, and therefore its
induction can result in relatively high levels of NO (Li and Billiar,
2000). Formation of high levels of NO (Xie et al, 1997) as a result
of iNOS induction had been reported for murine K1735 melanoma
cells, and a positive relation between iNOS inducibility, NO
formation, and apoptosis was suggested. Apoptotic resistance of
human melanoma cells due to a blockage in the apoptotic cascades
may be partly responsible for melanoma malignancy (Raisova et al,
2000). A pro-apoptotic effect of iNOS or the use of other pro-
apoptotic genes could also be applicable to overcome apoptosis
resistance of melanoma cells.
In order to investigate whether iNOS may play a part in
apoptosis induction in human melanoma, we studied its expression
and its apoptotic signi®cance in melanoma cell lines and in cultures
of NHM. Unexpectedly, iNOS mRNA was already detectable in
some of the melanoma cell lines analyzed when grown in the
absence of iNOS inducing agents. These cell lines originated from
melanoma metastases, whereas in melanoma cell lines originating
from primary tumors no iNOS mRNA was detectable.
The iNOS protein was detected by western analysis in NHM, in
melanoma cell lines and in the mammary carcinoma cell line
MCF-7 used as a control. Its estimated molecular mass of 150 kDa,
as determined by SDS±polyacrylamide gel electrophoresis, was
higher than its theoretical mass of 131 kDa deduced from the
protein sequence of hepatocyte iNOS (Geller et al, 1993). This
discrepancy may be due to protein modi®cation or to different
extraction and electrophoresis conditions applied. iNOS protein
bands of higher molecular masses have also been reported by others
(Chen and Mehta, 1996; Bansal et al, 1997; GarbaÂn et al, 1997;
Zadeh et al, 2000). Furthermore, the identity of the 150 kDa iNOS
protein could be con®rmed by western analysis using a second
iNOS-speci®c antibody.
In agreement with the RNA expression data, iNOS protein was
clearly inducible by TNF-a, IFN-g, and LPS in NHM and in
MCF-7 cells. In the melanoma cell lines analyzed, iNOS protein
was expressed weakly also when grown without cytokines and LPS;
however, in these cell lines inducibility of iNOS by treatment with
cytokines and LPS was lost. Lack of inducibility of iNOS has
already been shown for metastasizing subclones of the murine
K1735 melanoma cell line but no constitutive expression was found
(Dong et al, 1994; Xie et al, 1997). As the cell lines we analyzed also
originated from melanoma metastases, lack of iNOS inducibility
may be a general characteristic of melanoma cells with metastasizing
property. Unlike the K1735 subclones, however, the human
melanoma cell lines examined showed low levels of constitutively
expressed iNOS protein.
In melanoma cells, the absence of measurable amounts of nitrite
in the culture ¯uid may be due to low levels of enzymatically active
iNOS. On the other hand, the presence of nitrated proteins, for
which NO is essential, indicates that NO is produced intracellularly
also in melanoma cells. Although nitrite levels were slightly higher
in cultures of normal melanocytes as compared with melanoma
cells, less proteins with nitrotyrosine residues were detected. It is
tempting to speculate that the presence of a higher pool of free
tyrosine reported for melanocytes, which is necessary for
melanogenesis (Schallreuter, 1999), competes with protein associ-
ated tyrosine for nitration.
Although iNOS was inducible in normal melanocytes, our data
indicate that enhanced iNOS levels in cytokine- and LPS-treated
cells do not lead to higher NO levels. This may be due to
suboptimal conditions for iNOS enzyme activity. Tetrahydro-
biopterin, the essential cofactor of iNOS (Gross and Levi, 1992;
Figure 5. Reduced number of adherent cells in response to iNOS
inducing agents. O-Mel-2 and SK-Mel-19 melanoma cells and NHM
were grown for 72 h in the presence (+) or absence of TNF-a, IFN-g,
and LPS. Adherent cells were harvested by trypsin/ethylenediamine
tetraacetic acid and counted.










MCF-7 + ++ + + +
NHM + (++) + + +
O-Mel-2 + + + +
SK-Mel-19 + + + +
SK-Mel-23 + Not done + +
SK-Mel28 Not detectable Not done + +
Mel-2a Not detectable Not done + +
MeWo Not detectable Not done + +
aFor mRNA analysis, three independent cultures of NHM and six melanoma cell lines were investigated. Inducibility of iNOS mRNA was studied for the melanoma cell
lines SK-Mel-19 and O-Mel-2. For protein analysis, expression and inducibility of iNOS protein was investigated in six independent cultures of NHM and in six melanoma
cell lines.
b+, presence of iNOS mRNA or protein; ++, higher levels of iNOS protein/mRNA; (++), higher levels of iNOS RNA in one of three independent melanocyte
cultures.
VOL. 118, NO. 6 JUNE 2002 INOS AND APOPTOSIS IN MELANOCYTIC CELLS 1023
Tzeng et al, 1995), is also required for melanin formation and may
therefore be used up in melanocytes (Schallreuter, 1999).
In parallel to results described for pancreatic b-cells, macro-
phages, and murine melanoma cells (Dimmeler and Zeiher, 1997;
Xie et al, 1997) human SK-Mel-19 and O-Mel-2 melanoma cells
and three of seven NHM cultures showed elevated apoptotic rates
after addition of cytokines and LPS. The variable response of
normal melanocytes may be explained by different expression levels
of anti-apoptotic proteins in cells from different donors as we found
for bcl-2 (unpublished data). In contrast to the data reported for
metastasizing murine melanoma cells (which were resistant to
apoptosis induction by cytokines and LPS, in the human melanoma
cell lines we examined, which all derived from metastases),
apoptosis was inducible by cytokines and LPS. Furthermore,
neither inhibition of iNOS activity by L-NMMA nor addition of
the possibly limiting cofactor tetrahydrobiopterin showed any effect
on apoptosis induction. These data strongly indicate that iNOS
does not contribute substantially to apoptosis induction in human
melanoma cell lines and in cultures of normal melanocytes after
treatment with cytokines and LPS.
In agreement with our data, it was recently shown for murine
pancreatic b-cells that apoptosis in response to cytokines and LPS
was largely independent of iNOS activity (Liu et al, 2000). Also in
LPS-treated mouse macrophages, early apoptotic events were not
dependent on iNOS expression and NO formation (Xaus et al,
2000). Most likely, iNOS independent signaling cascades leading to
apoptotic cell death are activated in several cell types by cytokine
and/or LPS treatment in parallel to processes leading to the
induction of iNOS. These apoptotic effects may be caused by
TNF-a receptor activation (Xaus et al, 2000), ceramide signaling
(Geilen et al, 1997), or activation of transcription factor NF-kB
(Kasibhatla et al, 1998).
Overall, iNOS was inducible by cytokines and LPS in normal
melanocytes but not in human melanoma cells. Low constitutive
expression of iNOS protein found for melanoma cells may result in
a continuous formation of low amounts of NO, which may
Table II. Induction of apoptosis in NHM and in melanoma cell lines in response to TNF-a, IFN-g, and LPS is not
dependent on iNOS activity
Treatment of cellsa
Inducing agents ± + + + + ± ±
Cofactor ± ± ± + + ± +
Inhibitor ± ± + ± + + ±
Relative apoptotic ratesb
NHM I 1 3.1 3.4 3.5 3.2 0.8 1.2
NHM II 1 2.2 2.2 2.1 2.5 0.9 1
NHM III 1 4.2 4.7 5.1 4.3 3.6 1.6
Mean (6 SD) 3.1 (6 1.0) 3.4 (6 1.3) 3.6 (6 1.5) 3.3 (6 0.9) 1.8 (6 1.6) 1.3 (6 0.3)
SK-Mel-19/I 1 2.2 2.6 2.2 2.4 1.0 1.0
SK-Mel-19/II 1 4.6 4.3 4.6 5 1.8 1.9
SK-Mel-19/III 1 4 4.2 3.4 3.2 0.9 0.9
Mean (6 SD) 3.6 (6 1.2) 3.7 (6 1.0) 3.4 (6 1.2) 3.5 (6 1.3) 1.3 (6 0.5) 1.2 (6 0.4)
O-MEL-2/I 1 2.1 2.2 2.1 2.4 1.4 1.5
O-MEL-2/II 1 3.6 3.5 4.4 4.7 1.0 0.9
O-MEL-2/III 1 4.0 6.9 4.4 5.7 0.9 1.1
Mean (6 SD) 3.2 (6 1.0) 4.2 (6 2.5) 3.6 (6 1.4) 4.3 (6 1.7) 1.1 (6 0.2) 1.2 (6 0.2)
aDependency of apoptosis on iNOS activity was investigated by determination of relative apoptotic rates in melanocytic cells treated with inducing agents (TNF-a,
IFN-g, LPS) in the presence or absence of the NOS inhibitor L-NMMA and the NOS cofactor tetrahydrobiopterin. Relative apoptotic rates (apoptosis of treated cells as
compared with untreated controls), mean values (mean) and SD are shown. Apoptotic rates of untreated cells (control) were set to 1.
bThree NHM cultures derived from different foreskins were used, and three independent experiments were performed for each of the two melanoma cell lines SK-Mel-
19 and O-Mel-2.
Table III. Nitrite levels are not elevated in NHM in







Control 0.78 (0.12) 0.52 (0.04) 0.65 (0.13)
TNF-a, INF-g, LPS 0.58 (0.08) < 0.4 0.46 (0.08)
TNF-a, INF-g, LPS, NMMA 0.58 (0.11) 0.42 (0.08) 0.62 (0.02)
aNitrite levels were determined with 2,3-diaminonaphtalene in three cultures of
NHM (A±C), in untreated cells, in cells treated for 72 h with TNF-a, IFN-g, and
LPS, in cells treated in addition to the iNOS inhibitor L-NMMA. Mean values of
triplicate experiments and SD are given.
Figure 6. Nitrotyrosine is not increased in proteins of
melanocytic cells in response to cytokines and LPS. (A) Western
analysis for nitrotyrosine proteins of cellular extracts of normal
melanocytes (NHM-7), SK-Mel-19, and O-Mel-2 grown with (+) or
without (±) TNF-a, IFN-g, and LPS. (B) Colloidal Coomassie Brilliant
Blue staining of a SDS±polyacrylamide gel run in parallel to the gel used
in (A) demonstrating equal loading.
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subsequently activate or inhibit physiologic processes different from
apoptosis but important for tumor progression. In other studies,
physiologic processes due to constitutively expressed NOS had
already been investigated, as for example, for C3L5 murine
mammary adenocarcinoma cells, an enhancement of angiogenesis
and tumor cell invasiveness possibly caused by formation of low
amounts of NO, had been suggested (Jadeski and Lala, 1999;
Orucevic et al, 1999).
Loss of iNOS inducibility in melanoma cells reveals a clear-cut
difference from normal melanocytes, and this regulation defect may
be of importance for melanocytic transformation and malignancy.
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